Calcitonin gene-related peptide antagonists in pregnancy: a disproportionality analysis in VigiBase

Background Current evidence on the safety of calcitonin gene–related peptide antagonists (CGRP-A) in pregnancy for the treatment of both episodic and chronic migraine is scarce and does not yet provide definitive information. By querying VigiBase ® , the World Health Organization global pharmacovigi...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of headache and pain Vol. 25; no. 1; pp. 10 - 6
Main Authors:	Noseda, Roberta, Bedussi, Francesca, Gobbi, Claudio, Ceschi, Alessandro, Zecca, Chiara
Format:	Journal Article
Language:	English
Published:	Milan Springer Milan 19.01.2024 Springer Nature B.V BMC
Subjects:	Antagonists Brief Report Calcitonin Calcitonin gene-related peptide Calcitonin gene–related peptide antagonists Disproportionality Headache Internal Medicine Medicine Medicine & Public Health Migraine Neonates Neurology Pain Medicine Peptides Pharmacovigilance Pregnancy Safety VigiBase Pregnancy Disproportionality Safety VigiBase Calcitonin gene–related peptide antagonists
ISSN:	1129-2377, 1129-2369, 1129-2377
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!